Raymond James Financial’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
2,506
-3,303
-57% -$419K ﹤0.01% 4614
2026
Q1
$552K Buy
5,809
+729
+14% +$89.4K ﹤0.01% 4283
2025
Q4
$836K Buy
+5,080
New +$674K ﹤0.01% 3896
2025
Q3
– Sell
-1,140
Closed -$142K – 6142
2025
Q2
$142K Buy
+1,140
New +$147K ﹤0.01% 4693

Other funds holding NUTX

Raymond James Financial's NUTX Position: Q2 2026 in Review

Raymond James Financial reduced its Nutex Health (NUTX) stake by 57% in Q2 2026, selling an estimated $419K and leaving 2,506 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #4614.

Raymond James Financial first reported a position in NUTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $836K in Q4 2025. 153 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Raymond James Financial held 2,506 shares of Nutex Health worth $428K as of Q2 2026.
  • Raymond James Financial sold 3,303 Nutex Health shares in Q2 2026, an estimated $419K.
  • Nutex Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4614 holding.
  • Raymond James Financial first reported a position in Nutex Health in Q2 2025 and has held it in 4 quarters since.
  • Raymond James Financial's Nutex Health position peaked at $836K in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.